ZEISS Introduces VISULAS Combi in Canada

TORONTO, Canada | MARCH 21, 2025 | Carl Zeiss Meditec AG

ZEISS Medical Technology announced today the availability in Canada of the ZEISS VISULAS Combi, an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution. Designed for the treatment of retina, cataract, and glaucoma conditions, the ZEISS VISULAS Combi streamlines workflows with customizable modules, a uniform interface, and space-saving features. It enables seamless eye care without the need for time-consuming changes or relocation of the patient, enhancing both clinical efficiency and the patient experience.

Dr. Hady Saheb, a renowned glaucoma expert and President of the Canadian Glaucoma Society, shares, “As an ophthalmologist committed to delivering the best possible care for my patients, I am excited to see the ZEISS VISULAS Combi in practice. I had the opportunity to use the SLT component in conjunction with the ZEISS FORUM and Imaging Solution, and the experience was seamless. The ability to generate treatment reports automatically—without the need to manually enter every detail—is a time-saver for those using the ZEISS FORUM and Imaging Solution. Additionally, the HD Imaging Solution has been invaluable for educating the various learners on the team, eliminating the need for a co-observation tube and allowing multiple learners to watch simultaneously. The SLT laser is performed without bubbles, and the clinical results have also been very promising so far. The ZEISS VISULAS Combi promises to be an exciting new tool for our patients, as the role of SLT laser continues to expand in glaucoma patient care”